Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir

NCT04991402 is registered in ClinicalTrials.gov with Columbia University as lead sponsor.

NCT NCT04991402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04991402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir
Lead sponsor
Columbia University
Phase
Observational
Overall status
Completed
Start date
September 21, 2021
Completion date
May 30, 2025
Enrollment
1,920 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hiv, maternal obesity complicating pregnancy, maternal obesity during childbirth, obesity, obesity, infant